⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1759010 | 0.75 | — | — | |
| SCHEMBL1642834 | 0.75 | USP2 (0.52) | — | |
| Ethane Dimethane Sulfonate SCHEMBL4154177 | 0.73 | USP2 (0.67) | — | |
| Ethane Dimethane Sulfonate SCHEMBL4143911 | 0.73 | USP2 (0.67) | — | |
| Ethane Dimethane Sulfonate SCHEMBL4140371 | 0.73 | USP2 (0.67) | — | |
| Ethane Dimethane Sulfonate SCHEMBL4148513 | 0.73 | USP2 (0.67) | — | |
| Ethane Dimethane Sulfonate SCHEMBL4149477 | 0.73 | USP2 (0.67) | — | |
| SCHEMBL4153705 | 0.73 | USP2 (0.50) | — | |
| SCHEMBL4162427 | 0.73 | — | — | |
| Ethane Dimethane Sulfonate SCHEMBL1336145 | 0.72 | USP2 (0.75) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118159542-A | Substituted 2, 3-dihydro [1,3] thiazolo [4,5-b ] pyridines, salts thereof and their use as herbicidal agents | 拜耳公司 | 2024-06-07 | — | — | CN | claimed |
| US-20160200734-A1 | CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS | KANG, XINSHAN (CN) | 2016-07-14 | — | — | US | claimed |
| EP-3036237-A1 | CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS | Fujian Haixi Pharmaceuticals Co. Ltd (CN) | 2016-06-29 | — | — | EP | claimed |
| WO-2015024526-A1 | CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS | FUJIAN HAIXI PHARMACEUTICALS CO., LTD (CN) | 2015-02-26 | — | — | WO | claimed |
| US-20130210769-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY | IRM LLC (BM) | 2013-08-15 | — | — | US | claimed |
| US-8431607-B2 | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | IRM LLC, A DELAWARE LIMITED LIABILITY COMPANY (BM) | 2013-04-30 | — | — | US | claimed |
| EP-1838712-B8 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2011-10-12 | — | — | EP | claimed |
| EP-1838712-B1 | PYRAZOLOPYRIMIDINE COMPOUNDS AS ANTITUMOR AGENTS | ASTRAZENECA AB (SE) | 2011-03-09 | — | — | EP | claimed |
| US-20100234365-A1 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY | IRM LLC (BM) | 2010-09-16 | — | — | US | claimed |
| EP-2121598-A2 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY | IRM LLC (BM) | 2009-11-25 | — | — | EP | claimed |
| EP-0083439-B1 | 4-SULFIDO-OXAZA PHOSPHORINES AND THEIR USE IN THE TREATMENT OF CANCER, AND IN IMMUNOSUPPRESSION | ASTA Pharma AG (DE) | 1989-07-26 | — | — | EP | claimed |
| EP-0158057-B1 | SALTS OF OXAZAPHOSPHORINE DERIVATIVES | ASTA Pharma AG (DE) | 1989-04-26 | — | — | EP | claimed |
| US-4770870-A | BY ALSO ADMINISTERING A THIO COMPOUND, I.E. CYSTEINE; ANTICANCER AGENT | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1988-09-13 | — | — | US | claimed |
| EP-0265857-A1 | Water-soluble monoazodyes containing a ureido group and two sulfonyl fiber-reactive groups, process for their preparation and their use | HOECHST CELANESE CORPORATION (US) | 1988-05-04 | — | — | EP | claimed |
| EP-0254902-A2 | Solutions of oxazaphosphorins with enhanced stability and process for their preparation | ASTA Pharma Aktiengesellschaft (DE) | 1988-02-03 | — | — | EP | claimed |
| US-4618692-A | ANTITUMOR AGENTS | ASTA-WERKE AKTIENGESELLSCHAFT (DE) | 1986-10-21 | — | — | US | claimed |
| US-4591376-A | PLANT GROWTH REGULATORS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-05-27 | — | — | US | claimed |
| EP-0158057-A1 | Salts of oxazaphosphorine derivatives | ASTA Pharma AG (DE) | 1985-10-16 | — | — | EP | claimed |
| EP-0126234-A2 | 1,2,3-Thiadiazol-3-in-5-ylidene ureas, their preparation and compositions as plant-growth regulators and defoliants | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-11-28 | — | — | EP | claimed |
| EP-0083439-A2 | 4-Sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression | ASTA Pharma AG (DE) | 1983-07-13 | — | — | EP | claimed |